CDH1 and renal pelvis/ureter urothelial carcinoma: Overall, the pooled HR for RFS was 0.69 (95% CI, 0.44–1.09), suggesting that reduced E-cadherin expression does not correlate with poor prognosis for UTUC and there was significant heterogeneity between the studies (I2 = 63%, P = .04).